understand
interact
host
pathogen
import
develop
assess
medic
countermeasur
infecti
agent
includ
potenti
biodef
pathogen
bacillu
anthraci
ebola
viru
francisella
tularensi
review
focus
technolog
advanc
allow
interact
studi
much
greater
detail
name
use
omic
technolog
next
gener
sequenc
dna
protein
microarray
dissect
underli
host
respons
infect
molecular
level
optic
imag
techniqu
flow
cytometri
fluoresc
microscopi
assess
cellular
respons
infect
biophoton
imag
visualis
infecti
diseas
process
technolog
hold
great
promis
import
breakthrough
ration
develop
vaccin
therapeut
biodef
agent
understand
hostpathogen
interact
import
develop
assess
medic
countermeasur
infecti
agent
advent
new
imag
omic
technolog
provid
abil
follow
interact
whole
anim
cellular
molecular
level
enabl
greater
understand
mechan
involv
facilit
develop
refin
new
exist
vaccin
therapeut
exampl
advanc
bioimag
provid
noninvas
mean
identifi
intern
system
spread
infect
anim
model
impact
prophylaxi
therapi
diseas
process
combin
analysi
respons
cellular
level
use
flow
cytometri
microscopi
techniqu
use
microarray
also
enhanc
understand
host
respons
infect
provid
support
inform
help
elucid
innat
adapt
immun
mechan
essenti
protect
pathogen
well
virul
mechan
deploy
pathogen
although
infanc
next
gener
sequenc
also
hold
great
potenti
defin
hostpathogen
interact
review
assess
impact
technolog
abil
assess
host
respons
appli
help
progress
develop
vaccin
immunotherapi
biodef
agent
describ
center
diseas
control
prevent
cdc
select
agent
list
http
wwwselectagentsgov
biodef
agent
danger
pathogen
requir
high
level
biocontain
rel
lessstudi
compar
major
public
health
pathogen
case
rel
rare
therefor
studi
test
efficaci
therapeut
healthi
popul
endem
area
often
feasibl
use
anim
model
essenti
review
focus
use
new
techniqu
help
us
understand
host
respons
anim
model
well
human
context
omic
imag
technolog
hold
great
promis
import
breakthrough
ration
develop
vaccin
therapi
tradit
mani
immunolog
studi
focus
examin
singl
immun
paramet
cytokin
use
techniqu
like
elisa
elispot
approach
highlight
interconnect
pathway
control
immun
respons
host
encount
infecti
agent
emerg
transcriptom
technolog
microarray
nextgener
sequenc
thousand
paramet
immun
system
measur
time
genomewid
scale
allow
systemat
unbias
approach
understand
transcript
chang
correl
divers
state
immun
system
section
aim
review
use
microarray
nextgener
sequenc
relat
defin
host
respons
biodef
agent
vaccin
therapi
dna
microarray
consist
solid
surfac
usual
glass
microscop
slide
onto
dna
molecul
probe
picomolar
concentr
chemic
bond
purpos
microarray
detect
presenc
abund
label
nucleic
acid
target
biolog
sampl
hybridis
dna
array
level
bind
probe
target
quantifi
measur
fluoresc
emit
hybrid
target
scan
major
microarray
experi
label
nucleic
acid
deriv
mrna
sampl
tissu
microarray
measur
gene
express
microarray
prepar
cover
whole
genom
speci
howev
absenc
fulli
sequenc
organ
research
use
smaller
focus
array
design
public
avail
gene
sequenc
altern
whole
genom
microarray
use
relat
anim
predict
immun
profil
new
array
construct
use
crossspeci
hybridis
bioinformat
creat
probe
unsequenc
gene
kind
approach
current
supersed
use
nextgener
sequenc
analysi
gener
new
sequenc
inform
rapidli
accur
occas
inform
use
build
new
microarray
platform
success
exampl
appli
ferret
model
influenza
today
dna
microarray
construct
studi
gene
express
chang
number
differ
speci
includ
mous
rat
cow
dog
cat
chicken
hors
pig
rabbit
sheep
guinea
pig
ferret
chimpanze
marmoset
rhesu
cynomolgu
macaqu
dna
microarray
revolution
understand
host
gene
express
chang
respons
infect
variou
pathogen
inform
larg
obtain
vitro
infect
experi
primari
cell
taken
human
volunt
continu
cell
line
infect
incub
pathogen
differ
time
period
rang
hour
host
gene
signatur
gener
tabl
microarray
studi
perform
way
provid
insight
cellular
respons
follow
infect
instanc
monkeypox
viru
alkhalil
et
al
show
mani
gene
cell
underw
downregul
chang
follow
infect
monkeypox
viru
bourquain
et
al
also
found
major
unrespons
hela
cell
exposur
rubin
et
al
conclud
studi
differ
human
cell
type
monkeypox
viru
select
inhibit
express
gene
critic
role
cellsignal
pathway
activ
innat
immun
respons
tnf
thu
would
appear
monkeypox
viru
downregul
silenc
gene
host
less
respons
infect
dna
microarray
analysi
use
improv
understand
host
respons
follow
exposur
bacterium
spore
edema
toxin
lethal
toxin
bacillu
anthraci
caus
agent
anthrax
studi
human
peripher
monocyt
reveal
anthrax
lethal
toxin
target
multipl
normal
immuneregulatori
pathway
would
expect
protect
host
anthrax
infect
hypothesis
increas
level
decreas
along
impair
monocyt
function
facilit
bacteri
surviv
despit
readi
avail
dna
microarray
use
differ
anim
speci
rel
vivo
transcript
studi
publish
use
model
infect
biodef
infecti
agent
compar
public
health
pathogen
tuberculosi
tb
human
immunodefici
viru
hiv
use
mous
model
gene
signatur
determin
differ
organ
follow
infect
burkholderia
pseudomallei
venezuelan
equin
enceph
viru
veev
francisella
tularensi
recent
bovin
model
use
investig
host
mrna
express
chang
brucella
melitensi
examin
infect
peyer
patch
calf
ligat
ileal
loop
studi
show
earli
infecti
process
brucella
primarili
accomplish
compromis
mucos
immun
barrier
subvert
critic
immun
respons
mechan
microarray
studi
perform
use
nonhuman
primat
nhp
infect
ebola
viru
variola
viru
studi
public
health
england
mrna
profil
nhp
infect
monkeypox
viru
b
anthraci
current
underway
person
commun
karen
kempsel
scope
mani
inform
microarray
studi
perform
variou
anim
model
biodef
agent
protein
microarray
recent
technolog
provid
platform
highthroughput
proteom
construct
similar
dna
microarray
except
immobilis
speci
protein
peptid
array
aim
repres
partial
wholli
entir
proteom
two
method
protein
gener
use
standard
method
gene
protein
amplifi
clone
produc
vitro
express
system
typic
escherichia
coli
print
directli
onto
glass
human
plasma
healthi
recov
melioidosi
patient
burkholderia
pseudomallei
gene
express
chang
follow
intraven
infect
bacteria
balbc
mice
sentrix
cdna
array
illumina
liver
spleen
balbc
mice
burkholderia
pseudomallei
differ
gene
express
hour
exposur
b
pseudomallei
b
thailandensi
vitro
genechip
human
genom
affymetrix
human
lung
epitheli
cell
bacillu
anthraci
gene
express
chang
cell
expos
edema
toxin
genechip
murin
genom
affymetrix
raw
murin
macrophag
bacillu
anthraci
gene
express
chang
cell
expos
lethal
toxin
genechip
human
genom
plu
affymetrix
human
monocyt
blood
volunt
bacillu
anthraci
murin
macrophag
gene
express
chang
follow
exposur
protect
antigen
lethal
factor
b
anthraci
pcr
product
dna
array
raw
murin
macrophag
bacillu
anthraci
spore
gene
express
profil
human
macrophag
follow
infect
vitro
genechip
human
genom
plu
affymetrix
human
alveolar
macrophag
follow
bronchoscopi
brucella
melitensi
gene
express
analysi
mucos
epitheli
cell
follow
infect
vitro
human
est
microarray
microarray
centr
ontario
canada
epitheliallik
human
hela
cell
line
brucella
melitensi
kinet
human
antibodi
respons
acut
chronic
brucellosi
brucella
melitensi
protein
array
sera
brucellosi
patient
brucella
melitensi
investig
host
gene
chang
vivo
follow
infect
brucella
calf
ligat
ileal
loop
model
custommad
bovin
mer
oligo
array
infect
peyer
patch
calf
ligat
ileal
loop
brucella
melitensi
full
proteomewid
serolog
analysi
b
melitensi
human
protein
microarray
contain
protein
b
melitensi
sera
brucellosi
patient
coxiella
burnetii
profil
humor
immun
respons
acut
qfever
patient
protein
microarray
contain
c
burnetii
human
sera
qfever
patient
coxiella
burnetii
comparison
antibodi
profil
acut
chronic
qfever
patient
protein
microarray
contain
c
burnetii
human
sera
qfever
patient
coxiella
burnetii
defin
humor
immun
profil
use
qfever
patient
sera
custommad
protein
microarray
contain
protein
c
burnetii
human
sera
qfever
patient
ebola
marburg
virus
gene
signatur
follow
infect
vitro
ebola
viru
marburg
viru
human
cdna
array
agil
human
hepatoblastoma
cell
ebola
viru
entri
human
macrophag
infect
studi
vitro
genechip
human
genom
array
affymetrix
primari
human
macrophag
francisella
tularensi
live
vaccin
strain
lv
human
neutrophil
gene
express
vitro
infect
studi
genechip
human
genom
plu
affymetrix
polymorphonuclear
leukocyt
pmn
human
blood
francisella
tularensi
lv
vitro
infect
studi
use
human
pbmc
human
gene
array
affymetrix
human
peripher
blood
mononuclear
cell
pbmc
francisella
tularensi
gene
express
follow
inhal
f
tularensi
balbc
mice
mous
array
cover
gene
ocimumbio
lung
tissu
taken
infect
balbc
mice
journal
immunolog
research
pbmc
sampl
infect
monkey
yersinia
pesti
gene
express
chang
follow
infect
vitro
human
nylon
blot
cdna
spot
clontech
primari
human
monocyt
andor
mix
lymphocyt
pbmc
venezuelan
equin
enceph
viru
veev
gene
express
veev
infect
mice
gearray
focus
mous
tolllik
receptor
signal
microarray
veev
infect
mous
brain
mice
vaccin
anthrax
vaccin
adjuv
cpg
odn
measur
gene
express
chang
mice
splenocyt
treat
cpg
odn
murin
oligonucleotid
array
custommad
spleen
splenocyt
variou
bred
mice
francisella
tularensi
lv
assess
memori
respons
pbmc
taken
lv
vaccin
human
genechip
human
genom
affymetrix
restimul
pbmc
lv
vaccin
human
kill
francisella
tularensi
lv
adjuv
iscom
admix
cpg
defin
antibodi
profil
vaccin
mice
whole
proteom
microarray
custommad
balbc
mice
vaccin
lv
qfever
vaccin
assess
antibodi
immun
profil
qvax
vaccin
human
c
burnetii
protein
microarray
custommad
sera
vaccin
human
smallpox
vaccin
assess
antibodi
profil
gener
mva
andor
dryvax
smallpox
vaccin
protein
array
contain
vaccinia
viru
protein
mous
rabbit
macaqu
blacktail
prairi
dog
human
sera
human
genom
cdna
microarray
pbmc
rhesu
macaqu
infect
zebov
treat
shortli
exposur
rhapc
omiss
tabl
constitut
absenc
data
journal
immunolog
research
slide
altern
method
encod
dna
print
onto
slide
express
situ
time
requir
nappa
nucleic
acid
programm
array
one
power
applic
protein
microarray
studi
humor
immun
respons
infect
array
use
assess
host
antibodi
profil
immunosignatur
respons
infect
b
melitensi
b
pseudomallei
vacciniavariola
viru
monkeypox
viru
coxiella
burnetii
tabl
studi
c
burnetii
etiolog
agent
qfever
help
identifi
new
diagnost
antigen
seven
c
burnetii
protein
groel
ybgf
rpll
mip
omph
dnak
identifi
protein
array
studi
fabric
small
array
test
sera
patient
diseas
rickettsi
spot
fever
legionella
pneumonia
streptococc
pneumonia
well
qfever
order
develop
diagnost
assay
select
antigen
demonstr
moder
specif
recogn
qfever
patient
sera
use
protein
microarray
also
aid
identif
differ
igg
igm
profil
differenti
acut
chronic
qfever
proofofconcept
diagnost
assay
immunostrip
distinguish
two
diseas
state
addit
identifi
antigen
diagnost
tool
antibodi
profil
use
protein
array
also
provid
candid
antigen
subunit
vaccin
develop
therapi
microarray
technolog
use
help
understand
cellmedi
humor
immun
respons
follow
infect
infecti
agent
furthermor
also
improv
understand
mechan
action
therapeut
biodef
vaccin
instanc
transcriptom
approach
use
dna
microarray
use
assess
host
respons
treatment
therapeut
agent
rhapc
design
block
coagul
pathway
ebola
viru
infect
nhp
coagul
abnorm
ebola
hemorrhag
fever
previous
report
suggest
block
develop
coagulopathi
ebola
viru
infect
might
limit
pathogenesi
microarray
analysi
show
overal
circul
immun
respons
nhp
similar
presenc
absenc
coagul
inhibitor
howev
profil
surviv
nhp
treat
group
cluster
togeth
small
number
anim
surviv
treatment
group
studi
reveal
sever
differenti
express
gene
correl
surviv
name
chemokin
ligand
coagulationassoci
gene
tfpi
pdpn
work
clearli
need
area
gene
may
provid
possibl
target
earlystag
diagnost
futur
therapeut
limit
number
studi
perform
use
dna
microarray
understand
underli
protect
mechan
licens
novel
biodef
vaccin
dna
array
use
examin
immunostimulatori
properti
cpg
motif
use
adjuv
shown
significantli
prolong
protect
induc
anthrax
vaccin
adsorb
ava
recent
paranavitana
colleagu
examin
transcript
profil
human
volunt
receiv
live
vaccin
strain
lv
attenu
strain
f
tularensi
pbmc
individu
restimul
lv
vitro
memori
respons
evalu
microarray
result
reveal
dendrit
cell
macrophag
play
signific
role
antigen
present
significantli
differenti
express
gene
includ
gmcsf
well
gene
associ
tcell
bcell
natur
killer
cell
activ
identifi
paranavitana
et
al
conclud
manipul
dendrit
cell
matur
pathway
stimuli
promot
effici
antigen
present
may
way
forward
futur
vaccin
develop
francisella
antibodi
profil
evok
smallpox
vaccin
examin
detail
follow
develop
vaccinia
proteom
microarray
davi
et
al
sinc
immunosignatur
evok
three
differ
vaccin
dryvax
mva
mous
rabbit
macaqu
prairi
dog
human
defin
followup
studi
use
protein
array
involv
examin
sera
smallpoxvaccin
human
six
domin
antigen
identifi
compris
membran
nonmembran
antigen
intracellular
matur
virion
antigen
evalu
elisa
format
sera
mva
dryvax
vaccine
overal
elisa
aid
monitor
human
immun
respons
mva
vaccinia
previous
vaccin
individu
thu
assist
vaccin
develop
futur
protein
array
also
use
examin
immunosignatur
mice
vaccin
kill
f
tularensi
lv
adjuv
immun
stimul
complex
iscom
cpg
similarli
protein
array
use
assess
immunosignatur
qvax
qfever
vaccin
studi
identifi
protect
protein
aid
design
new
improv
vaccin
advanc
omic
technolog
also
assist
identif
candid
tcell
antigen
orfeom
flexibl
clone
approach
develop
jing
colleagu
whilst
analys
tcell
respons
vaccinia
viru
use
pbmc
smallpox
vaccin
individu
method
sinc
use
identifi
candid
tcell
antigen
herp
simplex
viru
type
could
appli
identif
tcell
antigen
biodef
vaccin
next
gener
sequenc
ng
also
known
highthroughput
shortread
deep
sequenc
revolutionis
sequencebas
analys
last
decad
underli
principl
use
micronanotechnolog
run
million
parallel
sequenc
reaction
gener
million
billion
base
per
run
log
greater
output
use
sanger
method
read
length
typic
compar
short
result
particular
base
sequenc
mani
time
known
coverag
read
depth
number
compet
platform
illumina
abi
solid
roch
ion
torrent
technolog
wide
use
differ
characterist
regard
averag
read
length
total
base
sequenc
per
run
costperbas
special
ng
technolog
pacbio
singl
molecul
real
time
smrt
oxford
nanopor
ng
technolog
appli
dna
dnaseq
rna
convers
cdnarnaseq
rnaseq
analysi
aim
identifi
transcriptom
complet
set
transcript
cell
includ
mrna
noncod
rna
small
rna
rnaseq
increasingli
use
altern
microarray
method
measur
gene
express
use
sequenc
read
depth
rna
speci
measur
absolut
level
sampl
two
method
high
degre
correspond
similar
analyt
statist
techniqu
use
although
data
preprocess
sampl
normal
requir
differ
bioinformat
techniqu
rnaseq
report
signific
advantag
microarray
less
biasvari
lower
background
signal
larger
dynam
rang
greater
importantli
depend
prior
knowledg
refer
transcriptom
therefor
lead
discoveri
previous
unknown
rna
speci
edit
rna
speci
splice
variant
howev
certain
disadvantag
exist
nonuniform
read
coverag
inabl
detect
rare
transcript
unless
high
read
depth
obtain
discrep
read
depth
librari
size
sampl
upon
infect
host
pathogen
chang
express
organ
occur
usual
investig
separ
due
low
pathogen
host
transcript
ratio
thu
enrich
pathogen
transcript
often
requir
pathogen
express
profil
exampl
includ
analysi
f
tularensi
transcriptom
infect
mous
macrophag
srna
express
yersinia
pesti
grown
vitro
mous
lung
rnaseq
use
investig
host
respons
differ
virul
strain
b
melitensi
mous
periton
macrophag
compar
previou
microarray
studi
deep
sequenc
provid
sensit
comprehens
unbias
coverag
host
transcriptom
mani
altern
novel
transcript
discov
particular
shown
live
attenu
vaccin
strain
reduc
abil
avoid
phagosomelysosom
fusion
activ
mapk
pathway
compar
virul
strain
may
account
differ
abil
two
strain
surviv
host
second
studi
examin
microrna
mirna
profil
cell
respons
b
melitensi
infect
also
use
high
throughput
sequenc
approach
zheng
colleagu
conclud
brucella
may
establish
chronic
infect
regul
host
mirna
profil
human
host
respons
dengu
viru
infect
also
report
use
rnaseq
signific
amount
previous
uncharacteris
gene
isoform
altern
transcript
rang
pathway
shown
particularli
greater
number
host
differenti
regul
transcript
upon
infect
attenu
denv
strain
wildtyp
suggest
may
previous
uncharacteris
innat
immun
respons
larg
evad
wildtyp
strain
ideal
would
prefer
monitor
gene
express
profil
pathogen
host
simultan
dual
rnaseq
approach
technic
bioinformat
challeng
may
well
becom
establish
method
howev
recent
exampl
exist
simultan
profil
host
viral
bacteri
speci
instanc
walter
colleagu
expos
mice
virul
f
tularensi
discov
acut
infect
four
hour
associ
mark
suppress
multipl
aspect
innat
immun
respons
rel
pathogen
examin
subset
immunerel
transcript
uniqu
induc
francisella
also
show
classic
inflammatori
respons
activ
lung
mice
hour
infect
simultan
correl
dramat
chang
bacteri
gene
express
pattern
result
help
identifi
potenti
virul
factor
target
host
inflammatori
pathway
futur
dual
rnaseq
also
use
evalu
immun
respons
follow
smallpox
vaccin
pbmc
taken
dryvax
vaccin
individu
either
stimul
without
live
vaccinia
viru
hour
result
show
detect
annot
vaccinia
gene
gene
classifi
earli
viral
life
cycl
express
significantli
higher
level
host
side
numer
innat
gene
pathway
activ
upon
vaccinia
infect
number
chemokin
cytokin
interferon
macrophageassoci
gene
exhibit
downregul
upon
infect
whilst
upregul
histon
ifn
ifn
heat
shock
protein
b
cell
repertoir
divers
immunolog
repertoir
term
defin
collect
surfaceexpress
bcell
bcr
tcell
receptor
tcr
receptor
divers
gener
dynam
sequenc
rearrang
specif
loci
germlin
genom
lead
vast
divers
differ
clone
classic
studi
immun
repertoir
use
techniqu
either
provid
limit
descript
sampl
limit
number
sequenc
eg
spectratyp
target
sequenc
highthroughput
natur
ng
technolog
allow
simultan
analysi
potenti
entir
immun
repertoir
singl
experi
use
dnaseq
rnaseq
recent
applic
includ
studi
chang
antibodi
respons
dengu
viru
infect
influenza
vaccin
clearli
scope
appli
techniqu
monitor
immun
repertoir
respons
infecti
diseas
vaccin
therapeut
imag
infect
use
optic
sourc
reli
detect
specif
target
use
fluoresc
bioluminesc
fluoresc
light
emit
characterist
emiss
spectrum
follow
excit
specif
wavelength
fluoresc
molecul
may
use
tag
specif
molecul
interest
often
molecul
interest
antibodi
turn
direct
specif
target
eg
surfac
receptor
host
cell
altern
endogen
protein
made
fluoresc
exampl
genet
modifi
anim
pathogen
fluoresc
dye
use
label
pathogen
cell
bioluminesc
produc
reaction
luciferas
enzym
substrat
requir
energi
oxygen
occur
unlik
fluoresc
imag
signal
still
detect
hour
host
die
bioluminesc
imag
requir
live
cell
section
aim
review
understand
biodef
pathogen
vaccin
immunotherapi
interact
host
greatli
aid
imag
techniqu
flow
cytometri
fluoresc
microscopi
real
time
vivo
biophoton
imag
techniqu
routin
use
import
tool
assess
cellular
respons
infect
vaccin
human
patient
anim
model
infect
use
cellular
phenotyp
function
assay
includ
fluorescencebas
prolifer
assay
beadbas
assay
also
avail
assess
level
solubl
factor
includ
cytokin
sampl
vitro
ex
vivo
tissu
intracellular
cytokin
respons
also
measur
intracellular
stain
fluorochrom
label
antibodi
determin
cellular
phenotyp
gener
follow
vaccin
therapeut
treatment
specif
antigen
antibodi
specif
cell
target
gener
avail
number
anim
speci
particularli
mous
rat
cell
target
rang
limit
less
commonli
use
speci
marmoset
turn
limit
analysi
cellular
respons
model
order
understand
hostrespons
fluoresc
label
pathogenspecif
antibodi
allow
presenc
intracellular
bacteria
identifi
within
host
cell
altern
bacteria
express
fluoresc
molecul
exampl
green
fluoresc
protein
gfp
mcherri
red
fluoresc
marker
may
use
combin
specif
antibodi
stain
host
cell
fluoresc
label
pathogen
allow
locat
pathogen
within
host
cell
identifi
vitro
vivo
infect
studi
use
flow
cytometri
immunofluoresc
microscopi
flow
cytometri
highlight
key
role
variou
cell
type
murin
infect
model
pesti
caus
agent
plagu
import
neutrophil
respiratori
pesti
demonstr
two
earli
studi
furthermor
flow
cytometri
use
identifi
target
host
cell
pesti
murin
pneumon
infect
model
alveolar
macrophag
identifi
initi
cell
type
uptak
bacterium
follow
neutrophil
addit
studi
investig
intratrach
inocul
pesti
show
interact
bacterium
airway
lung
deplet
cell
type
suggest
import
role
initi
replic
dissemin
pesti
lung
specul
differ
cellular
tropism
pesti
describ
respiratori
studi
mayb
due
differ
aerosol
intratrach
dose
differ
strain
organ
intraderm
model
infect
pesti
also
found
reduc
activ
inflammatori
cell
particularli
neutrophil
site
infect
use
bacteri
mutant
pesti
virul
plasmid
pyv
shown
involv
evas
earli
inflammatori
respons
skin
neutrophil
inflammatori
respons
characteris
follow
infect
mous
model
b
pseudomallei
burkholderia
mallei
flow
cytometri
neutrophil
found
crucial
protect
respiratori
intraperiton
form
relat
infect
role
neutrophil
burkholderia
infect
murin
host
also
align
human
ex
vivo
studi
phagocytosi
apoptosi
b
pseudomallei
human
blood
neutrophil
impair
neutrophil
diabet
patient
impair
neutrophil
function
may
contribut
increas
suscept
burkholderia
infect
observ
diabet
patient
use
flow
cytometri
understand
hostpathogen
interact
potenti
enabl
associ
host
immun
marker
protect
effect
follow
treatment
therapeut
vaccin
number
studi
assess
immun
respons
immunotherapeut
approach
treatment
infect
understand
potenti
protect
immun
respons
vivo
model
infect
use
immunostimul
includ
cpg
motif
one
studi
use
phosphoantigen
immunotherapi
marmoset
model
b
pseudomallei
infect
show
although
effect
surviv
strong
cellmedi
immun
respons
detect
could
inform
futur
treatment
strategi
anoth
studi
decreas
bacteri
number
increas
surviv
novel
immunotherapeut
strategi
use
acai
polysaccharid
pulmonari
f
tularensi
b
pseudomallei
infect
vivo
associ
ifnproduct
nk
cell
lung
flow
cytometri
beadbas
assay
potenti
aid
understand
potenti
protect
mechan
novel
immunotherapeut
assess
cytokin
respons
assay
use
studi
investig
effect
ifntherapi
mice
b
pseudomallei
infect
understand
chang
occur
result
treatment
antibiot
combin
therapi
studi
show
treat
mice
significantli
higher
ifnlevel
correl
surviv
also
use
understand
protect
immun
respons
involv
follow
journal
immunolog
research
combin
preexposur
vaccin
postexposur
cpg
immunotherapi
b
pseudomallei
infect
vivo
intranas
intraperiton
vaccin
attenu
vaccin
strain
found
gener
antigenspecif
cell
respons
greater
pulmonari
cell
respons
observ
follow
vaccin
via
intranas
rout
correspond
increas
protect
pulmonari
infect
immun
respons
elicit
vivo
follow
immun
ex
vivo
cellular
restimul
specif
antigen
vaccin
infect
anim
use
determin
specif
memorytyp
respons
vaccin
broaden
understand
number
vaccin
strategi
biodef
pathogen
includ
live
vaccin
b
pseudomallei
f
tularensi
novel
live
vaccin
strategi
f
tularensi
infect
heatkil
vaccin
b
mallei
potenti
immun
correl
protect
also
identifi
studi
compar
profil
lymphocyt
popul
follow
vaccin
prior
infect
respons
infect
monkeypox
viru
depth
assess
tcell
signatur
vaccin
individu
natur
acquir
f
tularensi
infect
suggest
signatur
could
use
identifi
protect
correl
immun
f
tularensi
addit
identif
put
vaccin
candid
longev
immun
respons
vaccin
also
greatli
aid
flow
cytometri
followon
studi
f
tularensi
live
vaccin
strain
lv
vaccin
immun
respons
vaccin
also
use
preclin
anim
model
murin
primat
phase
clinic
trial
assess
host
respons
recombin
plagu
vaccin
although
number
memori
cell
phenotyp
investig
flow
cytometri
lack
sensit
detect
chang
immun
profil
vaccin
placebo
group
understand
immun
respons
gener
novel
vaccin
facilit
ration
develop
vaccin
induc
appropri
immun
respons
protect
infect
exampl
engin
known
protect
pesti
includ
bcell
tcell
epitop
addit
examin
lymphocyt
respons
role
antigenpres
cell
gener
protect
immun
vaccin
b
pseudomallei
eg
dendrit
cell
dc
f
tularensi
lv
also
aid
use
flow
cytometri
techniqu
use
gfp
strain
intraderm
deliv
live
attenu
b
pseudomallei
vaccin
specif
cell
stain
demonstr
effici
cell
type
uptak
transport
bacteria
drain
lymph
node
neutrophil
fluorescentactiv
cell
sort
cdna
technolog
recent
use
togeth
gener
antigenspecif
monoclon
antibodi
overal
aim
provis
antibodi
treatment
infecti
diseas
exampl
alreadi
appli
emerg
coronaviru
speci
includ
sever
acut
respiratori
syndrom
sar
technolog
may
well
use
develop
therapeut
biodef
agent
futur
potenti
applic
flow
cytometri
biosecur
research
outsid
area
investig
hostpathogen
interact
review
marron
number
recent
advanc
fluoresc
microscopi
techniqu
confoc
microscopi
intravit
microscopi
dynam
live
cell
imag
super
resolut
microscopi
use
interrog
hostpathogen
interact
base
detect
specif
fluoresc
signal
provid
detail
imag
pathogen
colocalis
within
host
cell
fluoresc
microscopi
also
investig
util
diagnosi
infect
includ
b
pseudomallei
comparison
flow
cytometri
fluoresc
microscopi
provid
much
detail
assess
pathogen
interact
individu
host
cell
studi
aid
use
rang
fluoresc
dye
pathogen
cellular
structuresorganel
includ
dna
dye
dapi
import
nuclear
identif
fluoresc
microscopi
enabl
us
understand
intracellular
natur
nich
pathogen
abil
evad
immun
pathway
enabl
surviv
within
host
cell
exampl
identifi
lysosom
escap
mechan
f
tularensi
cytosol
provid
understand
abil
surviv
within
host
macrophag
fluoresc
microscopi
also
use
investig
role
complement
uptak
f
tularensi
cell
immun
evas
pathway
f
tularensi
also
use
understand
effect
modul
macrophag
function
phagosom
escap
f
tularensi
lv
interact
b
mallei
macrophag
vitro
assess
bacteri
compon
import
pathogenesi
diseas
understand
effect
f
tularensi
lv
strain
alter
interact
host
cell
potenti
implic
futur
licens
vaccin
understand
interact
f
tularensi
bacteria
host
cell
intracellular
natur
contribut
develop
treatment
regimen
includ
deliveri
antibiot
therapi
suitabl
treat
intracellular
infect
fluoresc
microscopi
also
potenti
elucid
host
pathway
target
could
therapeut
manipul
prevent
evas
host
respons
bacteria
aid
intracellular
clearanc
exampl
interact
f
tularensi
b
pseudomallei
pathway
autophag
digest
assess
use
fluoresc
microscopi
vitro
studi
interact
b
pseudomallei
autophagosom
use
raw
cell
fluoresc
label
bacteria
wildtyp
mutant
elucid
mechan
evas
autophag
pathway
b
pseudomallei
f
tularensi
also
found
util
one
autophag
pathway
surviv
studi
journal
immunolog
research
identifi
potenti
new
therapeut
compound
target
autophag
pathway
demonstr
induc
altern
autophag
pathway
use
novel
induc
reduc
bacteri
growth
f
tularensi
infect
confoc
scan
microscopi
enhanc
understand
interact
c
burnetii
hostcel
intracellular
vacuol
dynam
vacuol
lysosom
process
regul
actin
dynam
format
vacuol
includ
gtpase
associ
protein
investig
detail
use
c
burnetii
mutant
led
identif
host
target
potenti
therapeut
target
confoc
microscopi
also
utilis
develop
high
content
imag
assay
understand
format
multinucl
giant
cell
mngc
b
pseudomallei
infect
uniqu
mechan
use
burkholderia
spp
thought
allow
spread
infect
without
detect
immun
system
quantit
method
allow
effect
bacteri
mutant
thought
subvert
format
mngc
assess
importantli
method
also
use
investig
effect
small
molecul
inhibitor
mngc
format
thu
potenti
use
screen
tool
novel
therapeut
confoc
microscopi
also
use
investig
interact
viral
pathogen
includ
filovirus
ebola
viru
host
cell
map
interact
viral
protein
polymeras
l
cofactor
model
vitro
system
immunofluoresc
analysi
demonstr
interact
disrupt
mutant
contain
bind
site
led
reduc
ebola
viru
replic
thu
identifi
potenti
target
develop
novel
antivir
therapi
vivo
infect
model
f
tularensi
detect
phasecontrast
fluoresc
microscopi
use
situ
hybrid
mcherri
red
strain
b
melitensi
identifi
bacteria
associ
host
cell
tissu
section
vivo
infect
model
studi
show
situ
colocalis
b
melitensi
number
differ
cellular
phenotyp
within
granuloma
spleen
liver
understand
immunepatholog
lesion
use
complex
immunohistochemistri
fluoresc
bacteri
strain
potenti
allow
identif
new
treatment
bacteria
effect
evad
manipul
host
respons
enabl
surviv
bind
monoclon
antibodi
therapi
pesti
bacterium
use
immunofluoresc
demonstr
specif
potenti
therapi
bubon
plagu
prior
test
monoclon
antibodi
therapi
import
determin
specif
protect
observ
vivo
studi
intravit
microscopi
add
addit
paramet
time
microscopi
studi
use
identifi
rapid
neutrophil
respons
situ
intraderm
infect
dsred
express
pesti
strain
gfpexpress
neutrophil
transgen
mous
model
dynam
interact
dsred
pesti
gfpneutrophil
follow
intraderm
infect
associ
pesti
neutrophil
confirm
confoc
microscopi
specif
demonstr
within
hour
pesti
phagocytos
neutrophil
intracellular
associ
cell
led
author
investig
role
neutrophil
dissemin
plagu
lymph
node
use
antibodi
deplet
suggest
pesti
subvert
host
respons
earli
infect
prevent
dissemin
lymph
node
biphoton
imag
realtim
vivo
imag
visualis
infecti
diseas
process
occur
insid
live
anim
major
benefit
develop
medic
countermeasur
achiev
use
biphoton
imag
bpi
sensit
noninvas
method
detect
light
emit
either
bioluminesc
bl
fluoresc
fl
signal
use
photon
detector
base
charg
coupl
devic
ccd
camera
bpi
enabl
new
insight
pathogen
dissemin
host
respons
infect
interact
host
pathogen
effect
antimicrobi
vaccin
techniqu
also
use
refin
anim
experi
anim
act
control
therefor
increas
power
studi
creation
bl
fl
strain
pathogen
organ
enabl
field
progress
descript
process
involv
bpi
creation
strain
comprehens
review
andreu
et
al
use
bpi
differ
pattern
pathogen
dissemin
readili
observ
allow
discrimin
growth
spread
differ
form
pathogen
target
organ
depend
rout
infect
exampl
bl
express
variant
b
anthraci
stern
strain
produc
bl
signal
either
spore
germin
veget
growth
bacterium
permit
identif
site
germin
spread
earli
stage
anthrax
infect
bpi
studi
help
determin
site
anthrax
spore
germin
inhal
infect
light
emit
bacteria
upper
respiratori
tract
lung
observ
within
min
inhal
infect
bpi
studi
show
dissemin
pesti
found
vari
depend
rout
infect
subcutan
sc
administr
abdomin
linea
alba
region
result
pathogen
spread
inguin
lymph
node
ln
axillari
ln
liver
spleen
wherea
sc
infect
tradit
cervic
scruff
region
base
tail
footpad
ear
pinna
result
differ
pattern
signal
intens
origin
site
inject
intranas
challeng
bl
pesti
lead
detect
bl
signal
upper
abdomin
region
confirm
origin
lung
ex
vivo
imag
tissu
bpi
also
use
investig
dissemin
bl
strain
f
tularensi
type
schu
type
b
lv
visualis
area
bl
lv
infect
bacteri
spread
provid
import
inform
effect
instil
volum
anaesthesia
deliveri
bacteri
challeng
potenti
impact
wider
develop
vivo
pulmonari
infect
model
pattern
dissemin
bl
b
pseudomallei
follow
inhal
challeng
investig
spread
wild
type
capsul
mutant
strain
b
pseudomallei
compar
balbc
mous
model
immunocompent
hairless
mous
strain
particularli
use
fl
imag
studi
due
low
autofluoresc
background
usual
gener
fur
infect
studi
bl
strain
b
mallei
also
report
bl
signal
detect
lung
challeng
h
infect
pi
progress
liver
spleen
pathogen
dissemin
model
subsequ
use
assess
effect
antibiot
immunotherapi
substanti
reduct
bacteri
signal
found
b
malleiinfect
mice
treat
antibiot
levofloxacin
compar
untreat
mice
howev
antibiot
discontinu
h
pi
reemerg
bl
bacteri
signal
observ
mous
model
b
mallei
infect
use
investig
effect
cpg
treatment
alon
previous
shown
provid
protect
b
mallei
infect
given
preexposur
mice
mott
et
al
use
dual
signal
imag
elucid
role
cpg
neutrophil
activ
use
neutrophilspecif
fluoresc
probe
cyanin
peg
modifi
hexapeptid
reagent
specif
bind
formylpeptid
receptor
neutrophil
allow
realtim
colocalis
bl
bacteri
spread
fl
neutrophil
respons
lung
cours
infect
effect
immunis
protect
antigen
pa
vaccin
demonstr
immunis
mice
dissemin
bl
b
anthraci
beyond
nasopharynx
region
prevent
effect
pa
vaccin
immunis
anthrax
spore
germin
bacteri
spread
also
assess
work
clearli
demonstr
although
spore
germin
bacteri
growth
occur
rate
immunis
unimmunis
mice
bacteri
growth
quickli
neutralis
immunis
mice
wherea
bl
bacteria
spread
rapidli
unimmunis
control
bl
express
b
anthraci
strain
modifi
express
one
anthrax
toxin
stimul
differ
pattern
earli
immun
respons
cutan
infect
ear
pinna
studi
drain
ln
remov
follow
bpi
immun
cell
popul
analys
flow
cytometri
lethal
toxinexpress
strain
stimul
increas
total
cell
popul
neutrophil
tcell
wherea
immunosuppress
edema
toxinexpress
strain
stimul
increas
tcell
imag
flow
cytometri
recent
develop
flow
cytometri
includ
develop
imag
flow
cytomet
includ
imagestreamx
imag
flow
cytometri
add
anoth
dimens
flow
cytometr
applic
imag
cell
produc
addit
fluoresc
readout
abil
advanc
understand
hostpathogen
interact
particularli
suitabl
assess
colocalis
pathogen
within
host
cell
examin
cellular
process
uptak
process
pathogen
exampl
phagocytosi
autophagi
apoptosi
number
public
incorpor
use
imagestreamx
investig
hostpathogen
interact
grow
year
limit
number
public
wide
rang
public
health
relat
pathogen
includ
yersinia
enterocolitica
plasmodium
falciparum
neisseria
meningitidi
yet
studi
biodef
pathogen
publish
howev
pathogen
use
model
biodef
pathogen
yersinia
pseudotuberculosi
model
yersinia
pesti
document
demonstr
potenti
technolog
defens
scienc
technolog
laboratori
current
use
imagestreamx
examin
interact
b
pseudomallei
f
tularensi
pathogen
cellular
target
sampl
vivo
vitro
studi
figur
techniqu
potenti
provid
highthroughput
imag
techniqu
analysi
hostpathogen
interact
assess
immunotherapeut
biodef
pathogen
ultrasound
magnet
reson
imag
mri
radiographi
technolog
use
clinic
diagnosi
infecti
diseas
includ
anthrax
tuberculosi
technolog
use
biodef
research
exampl
positron
emiss
tomographi
pet
comput
tomographi
ct
imag
use
examin
inflamm
pattern
monkeypox
viru
infect
primat
use
imag
technolog
high
contain
alongsid
optic
imag
technolog
potenti
provid
multifacet
approach
imag
enhanc
understand
pathogenesi
infect
biodef
agent
futur
use
imag
technolog
potenti
applic
biodef
diseas
clinic
review
biodef
agent
danger
pathogen
pose
uniqu
challeng
research
human
case
diseas
rel
rare
therefor
anim
model
play
key
role
help
understand
pathogenesi
imag
omic
technolog
greatli
aid
abil
studi
host
respons
cours
infect
thu
provid
import
insight
also
sinc
neither
ethic
feasibl
conduct
convent
phase
iii
efficaci
trial
use
biodef
agent
human
volunt
key
technolog
play
import
role
evalu
vaccin
therapi
provid
evid
support
concept
defin
food
drug
agenc
fda
anim
rule
licens
new
medic
countermeasur
current
major
studi
use
omic
imag
techniqu
describ
review
examin
host
respons
independ
pathogen
virul
futur
howev
due
rapid
advanc
ng
platform
technolog
imag
technolog
anticip
examin
pathogen
virul
whilst
simultan
interrog
host
respons
achiev
overal
reduc
refin
anim
experi
thu
allow
identif
host
pathogen
marker
infect
time
enhanc
knowledg
hostpathogen
interact
aid
develop
vaccin
therapeut
danger
pathogen
